Traduction de «international level ●● developing » (Néerlandais → Français) :

Central to this endeavour are the six key factors which represent the FAMHP’s vision and ambition: ●● Recognition at national, European and international level ●● Developing partnerships with the healthcare
Central to this endeavour are the six key factors which represent the FAMHP’s vision and ambition: ●● Recognition at national, European and international level ●● Developing partnerships with the healthcare

The Resident Assessment Instrument (RAI) 444 is originally developed to Only for breast cancer and colon cancer, the US has higher survival rates assess the care needs of the elderly in institutions, and has later been than Belgium (data shown in documentation sheet in Supplement S1). To extended with instruments for different care settings and subgroups. In be able to distinguish the effect of early screening from the actual care, Belgium a national pilot project (the BelRAI) is ongoing, but is not yet implemented in all care settings: the assessment instruments for home care, relative survival rates should be compared across countries by stage, for long-term care facilities and acute care have already been adapted to information which is not yet available at international level. the Belgian situation (details in Appendix C).
Belgium a national pilot project (the BelRAI) is ongoing, but is not yet be able to distinguish the effect of early screening from the actual care, implemented in all care settings: the assessment instruments for home care, relative survival rates should be compared across countries by stage, for long-term care facilities and acute care have already been adapted to information which is not yet available at international level. the Belgian situation (details in Appendix C).

Key factor 1 Recognition at national, European and international level ●● Ensuring a strong, recognised identity, internally and externally ●● Implementing the spearheads ●● Ensuring proper coordination at European
Key factor 1 Recognition at national, European and international level ●● Ensuring a strong, recognised identity, internally and externally ●● Implementing the spearheads ●● Ensuring proper coordination at European

The FAMHP representatives at international level (e.g. CHMP, CVMP, CMD(h), CMD(v), COMP, HMPC and PDCO) are expected to cooperate closely with the three pillars.
The FAMHP representatives at international level (e.g. CHMP, CVMP, CMD(h), CMD(v), COMP, HMPC and PDCO) are expected to cooperate closely with the three pillars.

The FAMHP, as the competent national body, plays an active part in this work at international level through its representation on a number of formal and informal commissions, committees and working groups.
The FAMHP, as the competent national body, plays an active part in this work at international level through its representation on a number of formal and informal commissions, committees and working groups.

At present, a parallel circuit is under preparation at international level for dealing with this kind of problem.
At present, a parallel circuit is under preparation at international level for dealing with this kind of problem.

Recognition by the relevant parties at national level and by the other competent authorities at European level for early phase development has without a doubt been a significant achievement for the R&D department and the FAMHP.
Recognition by the relevant parties at national level and by the other competent authorities at European level for early phase development has without a doubt been a significant achievement for the R&D department and the FAMHP.

International representation Medicines and health products are the subject of extensive legislative harmonisation at European Community level.
International representation Medicines and health products are the subject of extensive legislative harmonisation at European Community level.

deoxyribonucleic acid hepatitis e antigen estimated date of delivery nzyme immunoassay evidence level enzyme-linked immunosorbent assay early-onset disease early-onset group B streptococcus European Union fasting plasma glucose fluorescent treponemal antibody absorbed test glutamic acid decarboxylase group B streptococcus glucose challenge test Guideline Development Group gestational diabetes mellitus general practitioner good practice point glucose tolerance test haemoglobin hepatitis B immune globulin hepatitis B surface antigen hepatitis B virus human chorionic gonadotrophin (can be total or free
ouble entry two step deoxyribonucleic acid hepatitis e antigen estimated date of delivery nzyme immunoassay evidence level enzyme-linked immunosorbent assay early-onset disease early-onset group B streptococcus European Union fasting plasma glucose fluorescent treponemal antibody absorbed test glutamic acid decarboxylase group B streptococcus glucose challenge test Guideline Development Group gestational diabetes mellitus general practitioner good practice point glucose tolerance test haemoglobin hepatitis B immune globulin hepatitis B surface antigen hepatitis B virus human chorionic gonadotrophin (can be total or free

International comparisons are of little help here since they are not care model focus on the development of “care networks” (the so-called interpretable without taking into account the organisation of care, which “Art.
International comparisons are of little help here since they are not “Art.